Willow Biosciences (FRA:3D7) Ending Cash Position : €0.22 Mil (As of Dec. 2024)

View and export this data going back to 2007. Start your Free Trial

What is Willow Biosciences Ending Cash Position?

Willow Biosciences's Ending Cash Position for the quarter that ended in Dec. 2024 was €0.22 Mil.

Willow Biosciences's quarterly Ending Cash Position increased from Jun. 2024 (€0.47 Mil) to Sep. 2024 (€0.57 Mil) but then declined from Sep. 2024 (€0.57 Mil) to Dec. 2024 (€0.22 Mil).

Willow Biosciences's annual Ending Cash Position declined from Dec. 2022 (€7.65 Mil) to Dec. 2023 (€2.15 Mil) and declined from Dec. 2023 (€2.15 Mil) to Dec. 2024 (€0.22 Mil).

Willow Biosciences Ending Cash Position Historical Data

The historical data trend for Willow Biosciences's Ending Cash Position can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Willow Biosciences Ending Cash Position Chart

Willow Biosciences Annual Data

Trend

Jun15

Jun16

Jun17

Jun18

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

Ending Cash Position

Get a 7-Day Free Trial

10.20

20.82

7.65

2.15

0.22

Willow Biosciences Quarterly Data
	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24
Ending Cash Position	Get a 7-Day Free Trial															2.15	1.10	0.47	0.57	0.22

Willow Biosciences Ending Cash Position Calculation

Ending Cash Position is the cash and cash equivalents balance at the end of the accounting period, as indicated on the Cash Flow statement. It is equal to the Beginning Cash Position plus the Net Change in Cash.

Willow Biosciences's Ending Cash Position for the fiscal year that ended in Dec. 2024 is calculated as

Ending Cash Position	=	Beginning Cash Position	+	Net Change in Cash
	=	2.108	+	-1.885
	=	0.22

Willow Biosciences's Ending Cash Position for the quarter that ended in Dec. 2024 is calculated as

Ending Cash Position	=	Beginning Cash Position	+	Net Change in Cash
	=	0.575	+	-0.352
	=	0.22

Willow Biosciences Ending Cash Position Related Terms

Thank you for viewing the detailed overview of Willow Biosciences's Ending Cash Position provided by GuruFocus.com. Please click on the following links to see related term pages.

Willow Biosciences Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Willow Biosciences Inc (FRA:3D7) » Definitions » Ending Cash Position

Comparable Companies

Traded in Other Exchanges

CANSF:USA 45CN:Germany WLLW:Canada

Address

202, 1201 5th Street SW, Calgary, AB, CAN, T2R 0Y6

Website

https://www.willowbio.com

Willow Biosciences Inc is a Canadian biotechnology company. It has only one reportable segment engaged in developing and producing high-purity, plant-derived ingredients for consumer care, food and beverage, and pharmaceutical products. It has a geographic presence in Canada and the United states, in which it generates the majority of its revenue from the United states.

Willow Biosciences Headlines

No Headlines